SOTIO® is developing the next generation of potent immunotherapies for patients
with cancer.

 

SOTIO’s robust clinical pipeline includes a differentiated superagonist of the attractive immuno-oncology target IL-15, a platform to streamline personalized active immune cell therapies and a new generation of potent and stable antibody-drug conjugates.

 

SOTIO® is focused on advancing safer
and more effective immunotherapies
through clinical development.

 

Join Our Team

SOTIO is shaping the future of cancer immunotherapies by translating compelling science into patient benefit. We are looking for talented, motivated, dynamic employees to join our international ...

Business Development

SOTIO aims to become a diverse oncology company that develops early stage candidates into marketed immunotherapy products. We seek to add to our portfolio projects that are at advanced preclinical or clinical stages.

NEWS

SOTIO Acquires Rights to BOXR CAR-T Platform from Unum

SOTIO will establish a T cell therapy R&D Center of Excellence in Cambridge, Massachusetts.  Unum’s former chief technology officer Geoff Hodge to join SOTIO to lead BOXR development team and all ...

SOTIO Programs

SO-C101

SO-C101 is an IL-15 superagonist that has been precisely designed and optimized for its use as a potent immunotherapy. It is currently being studied in an ongoing Phase 1/1b study …

DCVAC

DCVAC is a cell therapy platform designed to improve cancer outcomes by targeting multiple antigens and applying an immune-stimulatory technique. Multiple DCVAC candidates are in the clinical development …

Antibody-Drug Conjugates

SOTIO’s proprietary antibody-drug conjugate (ADC) platform yields potent and highly stable ADCs with a wide therapeutic window for the treatment of cancer …

Contacts

Boston
Boston
SOTIO LLC
180 Canal St,
Suite 300
Boston, MA 02114
USA
CONTACT
Prague
Prague
SOTIO a.s.
Jankovcova 1518/2
170 00 Prague 7
Czech Republic
CONTACT
Moscow
Moscow
SOTIO LLC
Pravdy Street, 8,
bld. 1 (8th Floor)
Moscow 125040
Russia
CONTACT
Beijing
Beijing
SOTIO Medical Research (Beijing) Co., Ltd.
Beijing Economic - Technological Dev. Area
99 Kechuang 14, 30-B
Beijing 100176
China
CONTACT
Basel
Basel
SOTIO Biotech AG
Hochbergerstr. 60C
4057 Basel
Switzerland
CONTACT